Literature DB >> 1924170

Column-switching high-performance liquid chromatography for on-line simultaneous determination and resolution of enantiomers of verapamil and its metabolites.

Y Oda1, N Asakawa, T Kajima, Y Yoshida, T Sato.   

Abstract

An on-line simultaneous assay for the enantiomers of verapamil (VA) and its three metabolites in plasma was developed with column-switching HPLC. This system consists of an ovomucoid protein chiral stationary phase coupled to an achiral reversed-phase column via a dilution tube and a trapping column. The reversed-phase column was used to separate and quantitate VA, its metabolites, and internal standard, without interference from plasma components. Then each of the eluates containing VA and its metabolites was selectively switched into a sampling loop, and the samples were transferred successively to the trapping column after dilution with a new mobile phase. After concentration on the trapping column, each sample was passed to the ovomucoid column, where the enantiomers were resolved and quantitated. The mobile phases for both HPLC columns were independently optimized and the diffusion of the sample during column switching was minimized. This method was shown to be efficient and reliable.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924170     DOI: 10.1023/a:1015848806240

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Direct resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate using a bovine serum albumin high-performance liquid chromatographic chiral stationary phase coupled to an achiral phenyl column.

Authors:  I W Wainer; R M Stiffin
Journal:  J Chromatogr       Date:  1988-01-22

2.  Separation of drug stereoisomers by the formation of beta-cyclodextrin inclusion complexes.

Authors:  D W Armstrong; T J Ward; R D Armstrong; T E Beesley
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

3.  Simultaneous quantitation of verapamil, norverapamil, and N-dealkylated metabolites in human plasma following oral administration.

Authors:  P A Kapur; T Law; E Watson
Journal:  J Chromatogr       Date:  1985-01-11

4.  Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.

Authors:  G Ellrodt; C Y Chew; B N Singh
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

5.  Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum.

Authors:  S C Cole; R J Flanagan; A Johnston; D W Holt
Journal:  J Chromatogr       Date:  1981-11-20

6.  Simultaneous determination of verapamil and its seven metabolites by high-performance liquid chromatography.

Authors:  M Kuwada; T Tateyama; J Tsutsumi
Journal:  J Chromatogr       Date:  1981-03-13

7.  Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.

Authors:  M Eichelbaum; G Mikus; B Vogelgesang
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

8.  Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism.

Authors:  H Echizen; B Vogelgesang; M Eichelbaum
Journal:  Clin Pharmacol Ther       Date:  1985-07       Impact factor: 6.875

9.  Immediate effects of intravenous verapamil in cardiac arrhythmias.

Authors:  L Schamroth; D M Krikler; C Garrett
Journal:  Br Med J       Date:  1972-03-11

10.  The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans.

Authors:  H Echizen; T Brecht; S Niedergesäss; B Vogelgesang; M Eichelbaum
Journal:  Am Heart J       Date:  1985-02       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.